Versigent
VGNT
445 hedge funds and large institutions have $3.03B invested in Versigent in 2026 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 129 increasing their positions, 146 reducing their positions, and 59 closing their positions.
279% more call options, than puts
Call options by funds: $21.1M | Put options by funds: $5.57M
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
22% more first-time investments, than exits
New positions opened: 72 | Existing positions closed: 59
0% more funds holding
Funds holding: 443 → 445 (+2)
3.7% less ownership
Funds ownership: 98.69% → 94.98% (-3.7%)
12% less repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 146
18% less capital inflows, than outflows
Capital inflows: $409M | Capital outflows: $499M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DME Capital Management
New York
|
+$42M |
| 2 |
Voss Capital
Houston,
Texas
|
+$38.9M |
| 3 |
Woodline Partners
San Francisco,
California
|
+$35.8M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$20.9M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$16.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
-$25.9M |
| 2 |
Soros Fund Management
New York
|
-$25.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$25.2M |
| 4 |
ExodusPoint Capital Management
New York
|
-$22.3M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$17.3M |
VGNT Hedge Fund Activity: Q3 2026 in Review
445 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Versigent (VGNT) for Q3 2026, worth a combined $3.03B — up 3.9% from $2.91B a quarter earlier.
Buyers outnumbered sellers: 72 funds opened new VGNT positions and 59 closed out — a net gain of 13 holders — while 129 added to existing stakes and 146 trimmed.
The largest buyer was DME Capital Management, adding an estimated $42M. The largest seller was Amundi, cutting an estimated $25.9M.
- 445 institutional investors held Versigent (VGNT) as of Q3 2026, up from 443 in Q2 2026.
- Funds reported $3.03B of Versigent stock for Q3 2026, up 3.9% quarter-over-quarter.
- 72 funds opened new Versigent positions in Q3 2026 and 59 closed out, a net change of +13 holders.
- The largest Versigent buyer in Q3 2026 was DME Capital Management, an estimated $42M added.
- The largest Versigent seller in Q3 2026 was Amundi, an estimated $25.9M sold.
Based on aggregated 13F filings for Q3 2026.